PHG - Philips gets FDA clearance for new MRI system MR 7700

Royal Philips (NYSE:PHG) said the U.S. Food and Drug Administration granted 510(k) clearance to its new magnetic resonance imaging system MR 7700 3.0T MR. The company said the XP gradients of MR 7700 provide high accuracy to support a confident diagnosis for patients. MR 7700 expands scanning capabilities with an integrated multi-nuclei imaging and spectroscopy solution to explore new clinical pathways. Philips noted that the new system integrates artificial intelligence for improved workflow to enhance patient and staff experience. The company said it will debut the MR 7700 at the International Society for Magnetic Resonance in Medicine annual meeting (May 7- May 12) in London. PHG -3.66% to $24.98 premarket May 9

For further details see:

Philips gets FDA clearance for new MRI system MR 7700